Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism
- PMID: 11520119
- DOI: 10.1006/exnr.2001.7732
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism
Abstract
Receptor-mediated interactions with amyloid beta-peptide (Abeta) could be important in the evolution of the inflammatory processes and cellular dysfunction that are prominent in Alzheimer's disease (AD) pathology. One candidate receptor is the receptor for advanced glycation endproducts (RAGE), which can bind Abeta and transduce signals leading to cellular activation. Data are presented showing a potential mechanism for Abeta activation of microglia that could be mediated by RAGE and macrophage colony-stimulating factor (M-CSF). Using brain tissue from AD and nondemented (ND) individuals, RAGE expression was shown to be present on microglia and neurons of the hippocampus, entorhinal cortex, and superior frontal gyrus. The presence of increased numbers of RAGE-immunoreactive microglia in AD led us to further analyze RAGE-related properties of these cells cultured from AD and ND brains. Direct addition of Abeta(1-42) to the microglia increased their expression of M-CSF. This effect was significantly greater in microglia derived from AD brains compared to those from ND brains. Increased M-CSF secretion was also demonstrated using a cell culture model of plaques whereby microglia were cultured in wells containing focal deposits of immobilized Abeta(1-42). In each case, the Abeta stimulation of M-CSF secretion was significantly blocked by treatment of cultures with anti-RAGE F(ab')2. Treatment of microglia with anti-RAGE F(ab')2 also inhibited the chemotactic response of microglia toward Abeta(1-42). Finally, incubation of microglia with M-CSF and Abeta increased expression of RAGE mRNA. These microglia also expressed M-CSF receptor mRNA. These data suggest a positive feedback loop in which Abeta-RAGE-mediated microglial activation enhances expression of M-CSF and RAGE, possibly initiating an ascending spiral of cellular activation.
Copyright 2001 Academic Press.
Similar articles
-
Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.J Neurosci Res. 2002 Nov 15;70(4):599-610. doi: 10.1002/jnr.10422. J Neurosci Res. 2002. PMID: 12404514
-
RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.Neurodegener Dis. 2009;6(5-6):270-80. doi: 10.1159/000261723. Epub 2010 Feb 10. Neurodegener Dis. 2009. PMID: 20145420
-
Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.Neurobiol Dis. 2010 Jan;37(1):67-76. doi: 10.1016/j.nbd.2009.09.008. Epub 2009 Sep 22. Neurobiol Dis. 2010. PMID: 19778613
-
The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.Curr Opin Investig Drugs. 2009 Jul;10(7):672-80. Curr Opin Investig Drugs. 2009. PMID: 19579173 Review.
-
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.Neurobiol Aging. 2011 May;32(5):763-77. doi: 10.1016/j.neurobiolaging.2009.04.016. Epub 2009 May 22. Neurobiol Aging. 2011. PMID: 19464758 Review.
Cited by
-
Exploring How Low Oxygen Post Conditioning Improves Stroke-Induced Cognitive Impairment: A Consideration of Amyloid-Beta Loading and Other Mechanisms.Front Neurol. 2021 Mar 24;12:585189. doi: 10.3389/fneur.2021.585189. eCollection 2021. Front Neurol. 2021. PMID: 33841293 Free PMC article.
-
Deleterious Alteration of Glia in the Brain of Alzheimer's Disease.Int J Mol Sci. 2020 Sep 12;21(18):6676. doi: 10.3390/ijms21186676. Int J Mol Sci. 2020. PMID: 32932623 Free PMC article. Review.
-
Alzheimer's genes in microglia: a risk worth investigating.Mol Neurodegener. 2023 Nov 20;18(1):90. doi: 10.1186/s13024-023-00679-4. Mol Neurodegener. 2023. PMID: 37986179 Free PMC article. Review.
-
Current therapeutic targets for the treatment of Alzheimer's disease.Expert Rev Neurother. 2010 May;10(5):711-28. doi: 10.1586/ern.10.29. Expert Rev Neurother. 2010. PMID: 20420492 Free PMC article. Review.
-
CD36 mediates the innate host response to beta-amyloid.J Exp Med. 2003 Jun 16;197(12):1657-66. doi: 10.1084/jem.20021546. Epub 2003 Jun 9. J Exp Med. 2003. PMID: 12796468 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials